Quizartinib is a pharmaceutical raw material and kinase inhibitor compound that functions as an FMS-like tyrosine kinase 3 (FLT3) inhibitor. It is a member of phenylureas, morpholines, benzoimidazothiazoles, and isoxazoles, and is investigated for its role as an antineoplastic agent and necroptosis inhibitor.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 950769-58-1
Quizartinib dihydrochloride
pharmaceutical raw material
Deoxycytidine
pharmaceutical raw material
Nemonoxacin malate
pharmaceutical raw material
Ipragliflozin L-proline
pharmaceutical raw material
Tafamidis meglumine
pharmaceutical raw material
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
CVWXJKQAOSCOAB-UHFFFAOYSA-N
CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3